Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
Apr 7, 2026, 18:18

Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions

Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn about a recent article by Paul C Evans, published in European Heart Journal, adding:

“A noticeable shift in cardiometabolic research is the move from isolated risk factors toward a more integrated, mechanism – driven view of disease.

Recent work highlights how obesity, type 2 diabetes, and dyslipidaemia interact across multiple cardiovascular conditions, rather than acting independently.

As biology becomes more interconnected, it reshapes how patients are stratified, how endpoints are defined, and how evidence is generated across the lifecycle.

For complex chronic diseases, the challenge is no longer identifying signals, but translating interconnected biology into coherent evidence that can inform decisions at scale.”

Title: Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities: A scientific statement of the ESC Council on Basic Cardiovascular Science, the ESC Working Group on Atherosclerosis and Vascular Biology, the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Myocardial Function, and the ESC Working Group on Cardiac Cellular Electrophysiology

Authors: Paul C Evans, Gemma Vilahur, Petra Kleinbongard, Elena Osto, Carol Ann Remme, Rosalinda Madonna, Dunja Aksentijevic, Harald Sourij, Sean M Davidson, Donato Santovito, Jürgen Gindlhuber, Christian Weber, Wolfgang A Linke, Esther Lutgens, Luc Bertrand, Dana Dawson, Magnus Bäck, G Danilo Norata, Johann Wojta, Cinzia Perrino

Read the Full Article on European Heart Journal

Vivek Das

Stay updated on all scientific advances with Hemostasis Today.